US Drug Recall Register
Class I · High risk Terminated Initiated Apr 12, 2022 (4 years ago)

Insulin Glargine

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Missing label on the vial

What was recalled

Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80

Recalling firm
Mylan Pharmaceuticals Inc
NDC code
49502-393-80
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0845-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Insulin recalls

See all
Class II · Moderate risk Completed

Sterile Diluent

Reason CGMP Deviations

Eli Lilly & Company D-0445-2024
Class II · Moderate risk Ongoing

Admelog

Reason Lack of Assurance of Sterility: Malformed crimped collar seal

Sanofi-Aventis U.S. LLC NDC 0024-5926-05 D-0575-2023
Class I · High risk Terminated

Insulin Glargine

Reason Labeling: Missing label: Label missing from some prefilled pens.

Mylan Pharmaceuticals Inc NDC 49502-394-71 D-1292-2022
Class I · High risk Completed

Humalog KwikPen

Reason TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Cardinal Health Inc. NDC 0002-8799-59 D-0882-2022
Class I · High risk Terminated

Semglee

Reason Labeling: Missing Label: label missing from some Semglee prefilled pens.

Mylan Pharmaceuticals Inc NDC 49502-0196-71 D-0462-2022